$ANTX

$3.50 -$0.13 (3.58%) After hours

$ANTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 37.7M shares outstanding

Who owns ANTX?

By type of holder

Institutions 65.2% Insiders 34.8% Everyone else 0.0%

Concentration Top 10 holders own 71.3%

Aziz Kabeer 19.8% · Leonard Braden Michael 8.5%

Institutional ownership

65.2%

+7.1 pts vs last qtr

Institutional holders

+14 vs last qtr

Net shares bought

+2.7M

by institutions in Q2 2026

New / sold out

28 / 14

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +1.3M
Citadel Advisors LLC +796.8K

Biggest sellers in Q2 2026

Woodline Partners LP −533.9K
Bank Of Nova Scotia SOLD OUT −459.2K

Who is planning to sell?

Notices of proposed sale, last 12 months

$6.08M

1 notice from 1 person

Shares covered

1.0M

2.68% of the company

Arranged in advance

100%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Readnour Robin Shane Director 10b5-1 $6.08M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+1045.3%

+83.96% a year

Each share's claim on the business

−91.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $28.4M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years19% 1–3 years15% Under 1 year67%

Quarterly turnover

21.0%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting ANTX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
VC Vivo Capital, LLC	3.2M	8.36%	Unchanged	Q1 '26	1.4%
Shares held by quarter Peak holding3.2M (Q1'26) Change over 8 quarters+3.2M Share of the company8.360% Vivo Capital, LLC's full portfolio →
CC Commodore Capital LP	2.9M	7.77%	+600.0K (+25.7%)	Q1 '26	0.9%
Shares held by quarter Peak holding2.9M (Q2'26) Change over 8 quarters+2.9M Share of the company7.770% Commodore Capital LP's full portfolio →

Vivo Capital, LLC

3.2M

% of company

8.36%

Change vs last qtr

Unchanged

Held since

Q1 '26

Commodore Capital LP

2.9M

% of company

7.77%

Change vs last qtr

+600.0K (+25.7%)

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding AN2 Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ANTX on Form N-PORT; together they hold 8.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$4.13M	853.0K	2.26%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$2.92M	603.1K	1.60%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$4.13M

% of company

2.26%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$2.92M

% of company

1.60%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding AN2 Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AK Aziz Kabeer Insider	7.5M	19.76%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company19.760% Aziz Kabeer's insider activity →
LB Leonard Braden Michael Insider	3.2M	8.53%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company8.530% Leonard Braden Michael's insider activity →

Aziz Kabeer

Insider

7.5M

% of company

19.76%

Change vs last qtr

—

Held since

—

Leonard Braden Michael

Insider

3.2M

% of company

8.53%

Change vs last qtr

—

Held since

—

13 more holders behind a free account

See every insider and 5%+ holder of AN2 Therapeutics Inc.

Comments